ResearcherBeijing University of Chinese MedicineActive in the last 2 years

Chuanbo Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0009-1636-5614; OpenAlex author ID A5052735757. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 3

Papers, trials and grants by year

2024: 1 paper · 2025: none · 2026: 1 paper

Papers 2

A Potential Target for Suppressing Pancreatic Cancer: PDGFRB Regulated by DNA Methylation. Last author DOI 10.2174/0113862073430277260109111343 ↗
Modulating pancreatic cancer microenvironment: The efficacy of Huachansu in mouse models via TGF-β/Smad pathway. Last author DOI 10.1016/j.jep.2024.117872 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yan Li · 1 shared paper, 2026 · strength 0.39
- Paper A Potential Target for Suppressing Pancreatic Cancer: PDGFRB Regulated by DNA Methylation. DOI 10.2174/0113862073430277260109111343 ↗
Quanwang Li · 1 shared paper, 2024 · strength 0.31
- Paper Modulating pancreatic cancer microenvironment: The efficacy of Huachansu in mouse models via TGF-β/Smad pathway. DOI 10.1016/j.jep.2024.117872 ↗
Yuehui Wang · 1 shared paper, 2024 · strength 0.31
- Paper Modulating pancreatic cancer microenvironment: The efficacy of Huachansu in mouse models via TGF-β/Smad pathway. DOI 10.1016/j.jep.2024.117872 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.